Skip to main content
PMC home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1973 Sep;32(5):436–443. doi: 10.1136/ard.32.5.436

Clinical trial of pentazocine in rheumatoid arthritis. Observations on the value of potent analgesics and placebos.

G Nuki, W W Downie, W C Dick, K Whaley, J B Spooner, M A Darby-Dowman, W W Buchanan
PMCID: PMC1006142  PMID: 4584572

Full text

PDF
436

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARCHER S., ALBERTSON N. F., HARRIS L. S., PIERSON A. K., BIRD J. G., KEATS A. S., TELFORD J., PAPADOPOULOS C. N. Narcotic antagonists as analgesics. Science. 1962 Aug 17;137(3529):541–543. doi: 10.1126/science.137.3529.541. [DOI] [PubMed] [Google Scholar]
  2. Alarcon R. D., Gelfond S. D., Alarcon G. S. Parenteral and oral pentazocine abuse. Johns Hopkins Med J. 1971 Dec;129(6):311–318. [PubMed] [Google Scholar]
  3. BATTERMAN R. C., GROSSMAN A. J. Effectiveness of salicylamide as an analgesic and antirheumatic agent; evaluation of the double blindfold technique for studying analgesic drugs. J Am Med Assoc. 1955 Dec 24;159(17):1619–1622. doi: 10.1001/jama.1955.02960340039009. [DOI] [PubMed] [Google Scholar]
  4. BEECHER H. K. The powerful placebo. J Am Med Assoc. 1955 Dec 24;159(17):1602–1606. doi: 10.1001/jama.1955.02960340022006. [DOI] [PubMed] [Google Scholar]
  5. Batterman R. C., Lower W. R. Placebo responsiveness--influence of previous therapy. Curr Ther Res Clin Exp. 1968 Mar;10(3):136–143. [PubMed] [Google Scholar]
  6. Batterman R. C. Methodology of analgesic evaluation: experience with orphenadrine citrate compound. Curr Ther Res Clin Exp. 1965 Oct;7(10):639–647. [PubMed] [Google Scholar]
  7. Beaver W. T., Wallenstein S. L., Houde R. W., Rogers A. A clinical comparison of the effects of oral and intramuscular administration of analgesics: pentazocine and phenazocine. Clin Pharmacol Ther. 1968 Sep-Oct;9(5):582–597. doi: 10.1002/cpt196895582. [DOI] [PubMed] [Google Scholar]
  8. Beckett A. H., Taylor J. F., Kourounakis P. The absorption, distribution and excretion of pentazocine in man after oral and intravenous administration. J Pharm Pharmacol. 1970 Feb;22(2):123–128. doi: 10.1111/j.2042-7158.1970.tb08404.x. [DOI] [PubMed] [Google Scholar]
  9. Boardman P. L., Hart F. D. Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis. Br Med J. 1967 Nov 4;4(5574):264–268. doi: 10.1136/bmj.4.5574.264. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chambers C. D., Inciardi J. A., Stephens R. C. A critical review of pentazocine abuse. HSMHA Health Rep. 1971 Jul;86(7):627–636. [PMC free article] [PubMed] [Google Scholar]
  11. DIAGNOSTIC criteria for rheumatoid arthritis: 1958 revision by a committee of the American Rheumatism Association. Ann Rheum Dis. 1959 Mar;18(1):49–53. [PMC free article] [PubMed] [Google Scholar]
  12. David-Chaussé J., Laporte G. L'administration du Fortal en rheumatologie. Bord Med. 1970 Apr;3(4):1151–passim. [PubMed] [Google Scholar]
  13. Donnelly P., Lloyd K., Campbell H. Indomethacin in rheumatoid arthritis: an evaluation of its anti-inflammatory and side effects. Br Med J. 1967 Jan 14;1(5532):69–75. doi: 10.1136/bmj.1.5532.69. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. FEARNLEY G. R., LACKNER R., MEANOCK R. I., BYWATERS E. G. Pilot study of intra-articular procaine and hydrocortisone acetate in rheumatoid arthritis. Ann Rheum Dis. 1956 Jun;15(2):134–139. doi: 10.1136/ard.15.2.134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. FREMONT-SMITH K., BAYLES T. B. SALICYLATE THERAPY IN RHEUMATOID ARTHRITIS. JAMA. 1965 Jun 28;192:1133–1136. doi: 10.1001/jama.1965.03080260021006. [DOI] [PubMed] [Google Scholar]
  16. Filler W. W., Jr, Filler N. W. Efect of a potent non-narcotic analgesic agnt (pentazocine) on uterine contrctility and fetal heart rate. Obstet Gynecol. 1966 Aug;28(2):224–232. doi: 10.1097/00003081-196608000-00016. [DOI] [PubMed] [Google Scholar]
  17. Frankendal B., Kjellgren O. Severe pain in gynecologic cancer. Trial of pentazocine, morphine, and a placebo. Cancer. 1971 Apr;27(4):842–847. doi: 10.1002/1097-0142(197104)27:4<842::aid-cncr2820270414>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  18. Gürtler J., Steiger J. Prüfung einer analgetischen Substanz im Doppelblindversuch (Pentazocine) Praxis. 1967 Aug 3;56(31):1074–1076. [PubMed] [Google Scholar]
  19. Hart F. D. Control of pain in the rheumatic disorders. Br Med J. 1968 Sep 14;3(5619):635–640. doi: 10.1136/bmj.3.5619.635. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Hart R. H. Pentazocine addiction. Lancet. 1969 Sep 27;2(7622):690–690. doi: 10.1016/s0140-6736(69)90393-6. [DOI] [PubMed] [Google Scholar]
  21. Hill R. C., Turner P. Importance of initial pain in post-operative assessment of analgesic drugs. J Clin Pharmacol J New Drugs. 1969 Sep-Oct;9(5):321–327. [PubMed] [Google Scholar]
  22. Kantor T. G., Sunshine A., Laska E., Meisner M., Hopper M. Oral analgesic studies: pentazocine hydrochloride, codeine, aspirin, and placebo and their influence on response to placebo. Clin Pharmacol Ther. 1966 Jul-Aug;7(4):447–454. doi: 10.1002/cpt196674447. [DOI] [PubMed] [Google Scholar]
  23. Ritchie D. M., Boyle J. A., McInnes J. M., Jasani M. K., Dalakos T. G., Grieveson P., Buchanan W. W. Clinical studies with an articular index for the assessment of joint tenderness in patients with rheumatoid arthritis. Q J Med. 1968 Jul;37(147):393–406. [PubMed] [Google Scholar]
  24. SUNSHINE A., LASKA E., MEISNER M., MORGAN S. ANALGESIC STUDIES OF INDOMETHACIN AS ANALYZED BY COMPUTER TECHNIQUES. Clin Pharmacol Ther. 1964 Nov-Dec;5:699–707. doi: 10.1002/cpt196456part1699. [DOI] [PubMed] [Google Scholar]
  25. Scott M. E., Orr R. Effects of diamorphine, methadone, morphine, and pentazocine in patients with suspected acute myocardial infarction. Lancet. 1969 May 31;1(7605):1065–1067. doi: 10.1016/s0140-6736(69)91704-8. [DOI] [PubMed] [Google Scholar]
  26. TRAUT E. F., PASSARELLI E. W. Placebos in the evaluation of treatment in rheumatic diseases. Ill Med J. 1959 Apr;115(4):181–183. [PubMed] [Google Scholar]
  27. TREADWELL B. L., SEVER E. D., SAVAGE O., COPEMAN W. S. SIDE-EFFECTS OF LONG-TERM TREATMENT WITH CORTICOSTEROIDS AND CORTICOTROPHIN. Lancet. 1964 May 23;1(7343):1121–1123. doi: 10.1016/s0140-6736(64)91804-5. [DOI] [PubMed] [Google Scholar]
  28. Taylor I. Clinical trial comparing pentazocine with pethidine and morphine in severe ischaemic limb pain. Br J Clin Pract. 1971 Jan;25(1):27–30. [PubMed] [Google Scholar]
  29. WRIGHT V. Some observations on diurnal variation of grip. Clin Sci. 1959 Feb;18(1):17–23. [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES